# A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication

> **NCT04660123** · PHASE4 · COMPLETED · sponsor: **Xijing Hospital of Digestive Diseases** · enrollment: 959 (actual)

## Conditions studied

- Gastric Cancer
- Helicobacter Pylori Infection
- Bismuth

## Interventions

- **DRUG:** Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication

## Key facts

- **NCT ID:** NCT04660123
- **Lead sponsor:** Xijing Hospital of Digestive Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-20
- **Primary completion:** 2021-12-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 959 (ACTUAL)
- **Last updated:** 2023-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04660123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04660123, "A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04660123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*